Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease
Crossref DOI link: https://doi.org/10.1007/s10620-017-4661-4
Published Online: 2017-06-30
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smits, Lisa J. T.
Grelack, Anna
Derikx, Lauranne A. A. P.
de Jong, Dirk J.
van Esch, Aura A. J.
Boshuizen, Ronald S.
Drenth, Joost P. H.
Hoentjen, Frank
License valid from 2017-06-30